In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3498-3500

  Yustes, Clara ^a   Guarro, Josep ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; FUNGUS GROWTH; FUNGUS ISOLATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG SYNERGISM; HUMANS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; SCEDOSPORIUM;

EID: 23044473260     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3498-3500.2005     Document Type: Article

References (24)

1. Andes, D. 2003. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob. Agents Chemother. 47:1179-1186.
2. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2001. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob. Agents Chemother. 45:327-330.
3. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2002. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob. Agents Chemother. 46:245-247.
4. Capilla, J., and J. Guarro. 2004. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob. Agents Chemother. 48:4009-4011.
5. Capilla, J., C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro. 2003. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47:3976-3978.
6. Capilla, J., C. Yustes, E. Mayayo, J. Fernández-Ballart, M. Ortoneda, F. J. Pastor, and J. Guarro. 2003. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection. Antimicrob. Agents Chemother. 47:1948-1951.
7. Denning, D. W. 2003. Echinocandin antifungal drugs. Lancet 362:1142-1151.
8. Ganesan, L. T., E. K. Manavathu, J. L. Cutright, G. J. Alangaden, and P. H. Chandrasekar. 2004. In vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. Clin. Microbiol. Infect. 10:961-966.
9. Girmenia, C., G. Luzi, M. Monaco, and P. Martino. 1998. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J. Clin. Microbiol. 36:1436-1438.
10. Jarvis, B., D. P. Figgitt, and L. J. Scott. 2004. Micafungin. Drugs 64:969-982.
11. Johnson, M. D., C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715.
12. Kontoyiannis, D. P., and R. E. Lewis. 2003. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist. Updates 6:257-269.
13. Kurtz, M. B., I. B. Heat, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
14. Meletiadis, J., J. F. G. M. Meis, J. W. Mouton, J. L. Rodriguez-Tudela, J. P. Donnelly, P. E. Verwey, and the EUROFUNG Network. 2002. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob. Agents Chemother. 46:62-68.
15. Meletiadis, J., J. W. Mouton, J. F. Meis, and P. E. Verweij. 2003. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob. Agents Chemother. 47:106-117.
16. Nakai, T., F. Ikeda, S. Tawara, K. Nishimura, and M. Miyaji. 2003. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob. Agents Chemother. 47: 1376-1381.
17. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Nesky, M. A., E. C. McDougal, and J. E. Peacock, Jr. 2000. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin. Infect. Dis. 31:673-677.
19. Ortoneda, M., J. Capilla, F. J. Pastor, C. Serena, and J. Guarro. 2004. Interaction of G-CSF and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn. Microbiol. Infect. Dis. 50:247-251.
20. Ortoneda, M., J. Capilla, F. J. Pastor, E. Mayayo, J. Fernández-Ballart, and J. Guarro. 2002. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J. Antimicrob. Chemother. 49:525-529.
21. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. Dupont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
22. Serena, C., F. J. Pastor, F. Gilgado, E. Mayayo, and J. Guarro. 2005. Efficacy of micafungin in combination in a murine model of disseminated trichosporonosis. Antimicrob. Agents Chemother. 49:497-502.
23. Steinbach, W. J., and J. R. Perfect. 2003. Scedosporium species infections and treatments. J. Chemother. 15:16-27.
24. Walsh, T. J., I. Lutsar, T. Driscol, B. Dupont, M. Roden, P. Ghahramani, M. Hodges, A. H. Groll, and J. R. Perfect. 2002. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr. Infect. Dis. J. 21:240-248.